Skip to content
Text “Loti” to 833-962-6682 to join the Loti Labs VIP Group!
Loti Labs Resources Peptides

Dihexa: Proposed HGF/MET Mechanism and Preclinical Evidence

Dihexa doesn’t fit neatly into any of the existing peptide categories researchers typically work with. It’s not a neurotransmitter precursor like much of the racetam-adjacent literature. It’s not a growth factor receptor agonist in the conventional sense. The origin story is worth knowing. Joseph Harding and Don Benson’s laboratory at Washington State University had been [...]

Dihexa doesn’t fit neatly into any of the existing peptide categories researchers typically work with. It’s not a neurotransmitter precursor like much of the racetam-adjacent literature. It’s not a growth factor receptor agonist in the conventional sense.

The origin story is worth knowing. Joseph Harding and Don Benson’s laboratory at Washington State University had been working on angiotensin IV analogs for years. The problem was always stability. AngIV degrades fast. Too fast to be a useful research tool in most in vivo applications.

Dihexa is a synthetic angiotensin IV-derived peptidomimetic with the reference structure N-hexanoyl-Tyr-Ile-6-aminohexanamide.

Proposed HGF/MET Mechanism and Evidence Status

HGF/MET modulation has been proposed as a mechanism for Dihexa. Benoist et al. published a mechanism paper in 2014; the journal retracted that paper in 2025. It should not be presented as establishing this mechanism.

Rat Behavioral Findings and Expression of Concern

McCoy et al. (2013) reported Morris water maze findings in scopolamine-treated and aged rat models, alongside hippocampal synaptogenesis experiments. The journal issued a separate expression of concern in 2021 for this preclinical study. These reports should be interpreted in light of that notice, which is distinct from the 2025 retraction of the 2014 mechanism paper.

The MET Receptor Problem Nobody Likes Talking About

Here’s the part of the Dihexa literature that isn’t discussed enough in research contexts: MET is an oncogene. In tumor biology, overactive HGF/MET signaling is a driver of invasion, metastasis, and drug resistance in a wide range of cancer types. MET amplifications and mutations are targeted by approved anti-cancer agents (cabozantinib, crizotinib in relevant indications).

Aged rodents have higher rates of spontaneous tumorigenesis than young animals. Studies using Dihexa in aged cohorts should include histopathological endpoints, tumor incidence monitoring, and ideally some assessment of systemic MET signaling in non-neural tissues.

This isn’t a reason to avoid the compound. It’s a reason to design studies thoughtfully. The neuro- and oncological dimensions of MET biology can both be true simultaneously.

Independent Replication: The Field Needs More of It

Independent replication is important when interpreting Dihexa findings from studies subject to these journal notices.

This is a standard scientific concern that applies to many research peptides, not an indictment of Dihexa specifically. The questions worth asking: Do the synaptogenesis findings replicate in different cell culture systems? Do the MWM effects hold across different rodent strains and at different ages? Do other labs see the same oral bioavailability? These are tractable experimental questions that the broader research community could reasonably address.

Working with Dihexa in the Lab: Practical Notes

Solubility: works in DMSO and slightly acidified aqueous solution (dilute acetic acid or HCl, pH around 5-6). For in vitro studies, keep DMSO vehicle under 0.1% : above that threshold, confounding cell biology becomes a real risk. For in vivo rodent work, the acidified saline formulation has been used successfully by the WSU group.

Storage: lyophilized powder at -20°C with desiccant is the standard. Don’t repeatedly freeze-thaw : aliquot from the start.

Assay selection: MET phosphorylation can be measured as a signaling endpoint, but such a readout alone does not establish direct binding of Dihexa to HGF or MET.

Interpreting the Evidence

The 2025 retraction and the separate 2021 expression of concern should be considered when evaluating the proposed mechanism and rat behavioral findings.

For laboratory research use only. Not for human consumption.

Research-use notice

This educational material discusses laboratory research concepts only. Loti Labs products are intended strictly for research and development use and are not for human consumption.

Ready to explore?

Browse high-purity research materials by format or view the full catalog.